Menu
Recruiting NCT07364019

The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia

No phase Interventional Dementia Prevention Subjective Cognitive Impairment Mild Cognitive Impairment Cognitive Change

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Brain Health PRO, Brain Health PRO.
Who it may be relevant to
Registry conditions: Dementia Prevention, Subjective Cognitive Impairment, Mild Cognitive Impairment, Cognitive Change. Basic parameters: 50 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Brain Health PRO Online Risk Factor Reduction Study for The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia

Overview

This study will recruit participants at risk for dementia to participate in an online educational program called Brain Health PRO (BHPro). The BHPro intervention is designed to address modifiable risk factors for dementia through a 6-month, fully online, educational program conveying the best available evidence for lifestyle changes that can mitigate dementia risk, and foster engagement toward one's own brain health. Achieving lifestyle changes in a diverse Canadian population through online education would be a major achievement in dementia prevention in Canada, with widespread personal and socioeconomic benefits. Eligible participants will be randomly assigned to either start Brain Health PRO immediately or in 6 months (delayed-start control group). All participants will have the opportunity to have access to BHPro for 6 months during the course of the study and will have open access to all content for 12 months following the initial 6-month intervention. Participation will last from 18-24 months depending on group assignment.

Interventions

  • Other Brain Health PRO
    Immediate start of 6-month Brain Health PRO Intervention
  • Other Brain Health PRO
    Delayed start of 6-month Brain Health PRO

Primary outcome measures

  • Change in modifiable risk factors as measured by a 7-item composite dementia risk factor score after 6 months. [Time frame: Change from baseline to month 6]
Secondary outcome measures (10)
  • Change in individual modifiable risk factors as measured separately by each of the 7 BHPro Lifestyle Risk Questionnaires after 6 months: Physical Activity [Time frame: Change from baseline to month 6]
  • Change in individual modifiable risk factors as measured separately by each of the 7 BHPro Lifestyle Risk Questionnaires after 6 months: Nutrition [Time frame: Change from baseline to month 6]
  • Change in individual modifiable risk factors as measured separately by each of the 7 BHPro Lifestyle Risk Questionnaires after 6 months: Sleep [Time frame: Change from baseline to month 6]
  • Change in individual modifiable risk factors as measured separately by each of the 7 BHPro Lifestyle Risk Questionnaires after 6 months: Cognitive Engagement [Time frame: Change from baseline to month 6]
  • Change in individual modifiable risk factors as measured separately by each of the 7 BHPro Lifestyle Risk Questionnaires after 6 months: Social and Psychological Health [Time frame: Change from baseline to month 6]
  • Change in individual modifiable risk factors as measured separately by each of the 7 BHPro Lifestyle Risk Questionnaires after 6 months: Vascular Health [Time frame: Change from baseline to month 6]
  • Change in individual modifiable risk factors as measured separately by each of the 7 BHPro Lifestyle Risk Questionnaires after 6 months: Vision and Hearing [Time frame: Change from baseline to month 6]
  • Change in self-efficacy as measured by the General Self-Efficacy Scale after 6 months. [Time frame: Change from baseline to month 6]
  • Change in dementia literacy as measured by the Alzheimer's Disease Knowledge Scale after 6 months. [Time frame: Change from baseline to month 6.]
  • Change in cognition as measured by the Cogniciti Brain Health Assessment after 6 months. [Time frame: Change from baseline to month 6]

Eligibility criteria

Inclusion criteria

  • Completion and documentation of the electronic Informed Consent Process (from the participant)
  • Sufficient proficiency in English or French to undergo online assessments and participate in an online educational program.
  • Technical ability to participate in an online educational program and remote assessments (i.e., regularly have access to a computer or tablet with an internet connection; have access to a desktop or laptop computer with an internet connection at least once every 6 months; ability to send and receive emails; ability to complete online assessments)
  • Sufficient vision to participate in an online educational program and complete online cognitive testing
  • Ages 50-80
  • Classified as being at increased risk of dementia based on at least one of the following:
  • First-degree family history of dementia
  • Education level at or below high school (grade 12 or less)
  • Self-Reported: Hypertension, Hypercholesterolemia, Body Mass Index > 30 kg/m2 (derived from NIH Metric BMI Calculator), or Physical Inactivity (active is defined as engaging in a minimum of 20- 30 min of physical activity causing sweating and breathlessness, at least 2 times a week)

Exclusion criteria

  • Individuals who have a clinical diagnosis of Dementia (based on self-report)
  • Individuals who are currently participating in or have participated in a past study involving BHPro

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Double blind
Primary purpose
Prevention

Study locations

Canada · 1 center
  • University of British Colubmia — Vancouver

Identifiers

NCT: NCT07364019 · H25-03523

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗